HGF Office

The Hague

Benoordenhoutseweg 46,
2596 BC The Hague,
Netherlands

View on Google Maps

Contact the office

HGF is dedicated to providing a comprehensive service both across the Netherlands and internationally. Contact us to find out how we can work with your business.

Tel. +31 (0)70 240 0899

Email our team

HGF in the Hague opened in 2015 to cater for clients in the Benelux, providing direct representation at proceedings at the European Patent Office branch located in the Hague. Our attorneys can act directly before the EPO, the Dutch and the Belgian patent office, and file trade marks and designs at the Benelux Office for Intellectual Property.

Well-connected with the universities and small businesses in the area, our attorneys possess expertise in a range of fields including chemistry, life sciences, polymer sciences, bio sciences and pharmaceuticals. The team also collaborates with the firm’s multidisciplinary specialists across the company to offer IP services spanning trade marks, engineering and electronics.

Our team: The Hague

Search for a specialist

    Use the options below to select one or more search areas

    UPC Representative

    Achim
    Krebs

    Partner & Patent Attorney
    UPC Representative

    Jessica
    Kroeze

    Partner & Patent Attorney
    UPC Representative

    Nienke
    Lubben

    Partner & Patent Attorney
    UPC Representative

    Vincent
    Van Der Mark

    Senior European Patent Attorney

    Ronald
    A. Schapira

    Consultant

    Silvia
    Marton

    Senior European Patent Attorney

    Dominique
    Dutree

    Patent Formalities Assistant

    Isabelle
    Vinkeles Melchers

    IP Administration Manager

    Sebastiaan
    Albers

    Patent Formalities Officer

    Noa
    Aga

    Patent Formalities Assistant

    Michael
    Kramer

    Senior Patent Formalities Officer

    Latest updates

    PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

    HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

    Read article

    G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

    Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

    Read article

    The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

    The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

    Read article

    How France's investment in digital health, AI, and bioinformatics is transforming the intellectual property (IP) landscape

    In recent years, France has become a key player in digital health innovation, driven by strategic government investments under the France 2030 initiative and the French Tech 2030 program. These …

    Read article
    Event - 14th October 2025

    The Future of Protein Production Amsterdam 2025

    HGF are proud to be sponsoring the Future of Protein Production Amsterdam 2025, the leading global event bringing together innovators across fermentation, cultivated and plant-based proteins. Date: 29-30th October 2025  …

    Event details

    A Turning Point for AI Patent Eligibility?

    Director Squires Vacates PTAB § 101 Rejection in DeepMind Case In a notable early move as Under Secretary of Commerce and USPTO Director, John Squires has vacated a Patent Trial …

    Read article

    T 0792/24: Novelty and Inventiveness of Second Medical Use Claims

    The EPO Board of Appeal’s decision in T 0792/24 provides helpful guidance on the assessment of novelty and inventive step for European second medical use claims. In light of a …

    Read article
    See all updates